president

PhDr. Ladislav Csémy, psychologist

Researcher in epidemiology, addictions and social psychiatry at the National Institute of Mental Health (NIMH). Dr. Csémy graduated from Psychology at the Faculty of Arts of the Charles University in Prague. For a long time, he has been working at NIHM as the Head of the Centre for Epidemiological and Clinical Research on Addictions. 

His professional interests include psychological and social-medical aspects of addictive behaviour, psychiatric epidemiology and health psychology.

Dr. Csémy contributed to more than ten monographs and has worked on a number of research studies and community-based prevention projects. In the past, he received the professor Vladimir Vondracek’s National Psychiatric Award for his research work.

SCIENTIFIC BOARD

Doc. MUDr. Viktor Mravčík, Ph.D., doctor

Doc. MUDr. Viktor Mravčík, Ph.D., is the Head of the National Monitoring Center for Drugs and Addictions (NMS) in Prague. He participated in many international projects concerning drug policies and drug monitoring. He has a rich experience with educational activities with his peers from countries which either prepares for monitoring standards of the European Monitoring Centre for Drugs and Addiction (EMCDDA) or wants to deepen their competence in this area.

Doc. Mravcik teaches methodology and drug epidemiology at the Department of Addictology of the First Faculty of Medicine at the Charles University in Prague. He is also a research associate of the National Institute of Mental Health (NIMN) and a member of the board of the doctoral program in addictology at the First Faculty of Medicine of the Charles University. 

Moreover, Doc. Mravcik is a member of the Committee on Addictive Diseases of the Czech Medical Association of J.E. Purkyne , member of the editorial board of the Journal on Addictology and the winner of the award of the Journal of Czech Physicians for the best work in 2010. Last but not least, he received the Josef Skala’s award for his publication activities in the field of addictology in 2017. 

Prof. MUDr. Eva Králíková, CSc., doctor

Prof. MUDr. Eva Kralikova, CSc. has been involved in epidemiology, prevention and treatment of tobacco dependence for nearly 30 years. Currently, she is a teacher at the Institute of Hygiene and Epidemiology of the First Faculty of Medicine of the Charles University in Prague and at the General University Hospital in Prague. 

Prof. Kralikova leads the Centre for Tobacco Addicted at the Third Internal Clinic of the First Faculty of Medicine of the Charles University. She is also chairwoman of the Society for the Treatment of Tobacco Addiction (see: www.slzt.cz).

Univ. Doz. Dr., Ernest Groman, doctor

Univ. Doz. Dr. Ernest Groman is a Scientific Director of the Nicotine Institute in Vienna. In the past, he worked for the Public Health Center (Institute of Social Medicine of the University of Vienna). Since 2002, he has been involved in the development and implementation of smoking cessation programs in Lower Austria. His scientific activities and intervention projects have covered more than 76 cities in Lower Austria with a combined population of around 1.6 million people. 

Doc. Groman also worked as a Scientific Advisor to the Austrian government, the Austrian Pharmaceutical Chamber, and the Austrian smoking cessation hotline. He represented Austria as a delegate to the WHO in the context of the negotiations on the Global Framework Convention on Tobacco Control.

Ernest Groman graduated from the Medical Faculty of the University of Vienna. In his habilitation procedure, he specialized in tobacco and public health issues. In this area, he wrote  more than 100 professional articles and a co-authored several books.

RNDr. Ladislav Kážmér, Ph.D.

RNDr. Ladislav Kážmér, Ph.D., completed his postgraduate studies in the field of social geography at the Faculty of Science, Charles University in Prague. He completed his master’s studies at Comenius University in Bratislava, Slovakia. In his work, he focuses on the issues of social and socio-spatial determinants of population health.

Dr. Fabian Pitter Steinmetz

Fabian Pitter Steinmetz is certified toxicologist working for the international consultancy Delphic HSE. After some experience in the pharmaceutical industry, he completed his PhD in predictive toxicology at Liverpool John Moores University in 2016. Scientifically, he is interested in quantitative structure-activity relationships, novel psychoactive substances, but also in regulatory approaches focussing on harm reduction. He is active in several national and international organisations that advocate for drug policy reform.

Jakub Popík, E.MA.

Jakub Popík is a human rights officer, PhD student at the Institute of Sociology of the Slovak Academy of Sciences, drug policy advisor and director of the Harm Reduction Institute. In his work, he seeks to improve communication and cooperation between entities tasked with the protection of human rights, whether from the media, non-profit, state, or private sector, in order to eliminate all forms of prejudice from society.

Krzysztof Łanda, M.D.

Currently he holds position of the President of the Ukrainian Society of Evidence Based Health Care. He is a Partner in the HTA Formedis Ltd. and the CEO of MedInvest Scanner Ltd., a company dealing with market access, pricing and reimbursement, due diligence and evaluation of innovativeness of health technologies before marketing authorization. 2023-2024 he lived in Kyiv holding a position of an Advisor to the Minister of Health in Ukraine. Krzysztof was the Deputy Minister of Health in Poland in 2015-2017 and was responsible for drug policy, reimbursement and prices of medical devices, mapping of health needs, investments in health care, prices of health services and the basic benefits package. 2017-2018 he used to work for DBSE and was a member of the international Dentons Pharmaceutical Law and Health Care team. Krzysztof was previously the CEO of HTA Audit, a company dealing with the quality assessment of HTA reports addressed to authorities and public institutions and the President of the Watch Health Care Foundation. In 2010-2011 he was President of the Central & Eastern European Society of Technology Assessment in Health Care. In 2006-2007 was a Director of the Drug Policy Department in the Central Office of the National Health Fund in Poland. In 2004 Krzysztof was elected to the Board of Directors of Health Technology Assessment International (HTAI) where he remained until mid-2007. In 2010-2012 Krzysztof led capacity building in HTA in Ukraine and in Kazakhstan, also in 2006-2008 in Serbia. He was a team leader of a World Bank project aimed at introducing EBHC principles in Serbia.

REGULATORY BOARD

Tomáš Sadílek

Tomáš Sadílek has an extensive experience working for the Office of the Government of the Czech Republic in the field of legal and illegal drugs. He represented the Czech Republic in drug-related meetings in the United Nations institutions in Vienna and New York and in meetings in the EU area, Eastern Partnership countries area, and the US.

Mgr. Mikuláš Peksa, Ph.D.

Mgr. Mikuláš Peksa, Ph.D., is CEO of Cybermindnet. Studied biophysics at Charles University in Prague. Between 2017 and 2019 active as Member of Czech Parliament, 2019 to 2024 as Member of European Parliament.